Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 11241 clinical trials
Psychotherapy (Accelerated Resolution Therapy) for Cancer Related Trauma and Distress

This study may provide evidence to support integration of accelerated resolution therapy into psychological treatment of cancer patients, which may decrease cancer related trauma and distress.

psychosis
psychotherapy
depressive symptoms
cancer
hematopoietic and lymphoid cell neoplasm
  • 0 views
  • 16 Feb, 2024
  • 1 location
  • 0 views
  • 17 Apr, 2023
  • 3 locations
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will concurrently enroll patients with four distinct advanced malignancies in 5 separate tumor cohorts.

seizure
stage iv nsclc
ipilimumab
endometrial adenocarcinoma
systemic therapy
  • 0 views
  • 16 Feb, 2024
  • 9 locations
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3602 Capsule

This is a study to evaluate the tolerance, dose-limiting toxicity (DLT), phase II recommended dose (RP2D), and maximum tolerated dose (MTD) of single and multiple oral doses of TQB3474 in patients with advanced malignant tumors.

refractory multiple myeloma
multiple myeloma
cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
Decitabine With Ruxolitinib or Fedratinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

This phase II trial studies how well decitabine with ruxolitinib or fedratinib works before hematopoietic stem cell transplant in treating patients with accelerated/blast phase myeloproliferative neoplasms (tumors). Drugs used in chemotherapy, such as decitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, …

blood count
hydroxyurea
myelodysplastic syndromes
leukapheresis
tumor burden
  • 0 views
  • 16 Feb, 2024
  • 1 location
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

docetaxel
testosterone
antiandrogen therapy
enzalutamide
cancer
  • 0 views
  • 16 Feb, 2024
  • 22 locations
Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial

PEGASUS is a prospective multi-centric study designed to prove the feasibility of using liquid biopsy to guide the post-surgical and post-adjuvant clinical management in 140 microsatellite stable Stage-III and T4N0 Stage-II colon cancer patients.

folfiri regimen
stage ii colon cancer
endoscopy
cancer
adjuvant
  • 0 views
  • 16 Feb, 2024
  • 9 locations
Impact of Acetazolamide in Reducing Referred Postoperative Pain

Robotic assisted laparoscopic prostatectomy (RALP) is the standard treatment for prostate cancer, due to the benefits of decreased blood loss and length of stay.The procedure involves removing a man's prostate using a minimally invasive robotic approach under the guidance of a surgeon.

acetazolamide
laparoscopic procedures
laparoscopy
prostatectomy
cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours

This is a phase I study of 177Lu-DOTA-TATE in combination with the PARP-inhibitor olaparib for treatment of patients with somatostatin receptor positive tumours detected by 68Ga-DOTA-TATE/TOC PET. The combination of a PARP inhibitor that will specifically target the repair mechanism, with ionising radiation causing SSB's might overcome the repair dependent …

somatostatin
hormone levels
neuroendocrine tumors
parp inhibitor
complete resection
  • 0 views
  • 16 Feb, 2024
  • 1 location
Microbiome and Rectal Cancer

The purpose of our study is to determine if an association exists between the microbiome of those with rectal adenocarcinoma who are complete pathologic responders and those who have a partial or no response to neoadjuvant therapy.

adenocarcinoma
chemoradiotherapy
rectal carcinoma
neoadjuvant therapy
cancer
  • 0 views
  • 16 Feb, 2024
  • 3 locations